Sex differences in ICD benefit

Journal of Electrocardiology

Volumn 47, Issue 6, 2014, Pages 869-873

  Bergau, Leonard ^a   Seegers, Joachim ^b   Zabel, Markus ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Gender Sex; Implantable cardioverter defibrillator; Prophylactic therapy; Risk factors

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BLOOD VESSEL INJURY; COMORBIDITY; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MORTALITY; PERICARDIAL EFFUSION; PNEUMOTHORAX; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SHOCK; SUDDEN CARDIAC DEATH; SURVIVAL; ADULT; AGED; EVIDENCE BASED MEDICINE; FEMALE; HEART FAILURE; MALE; META ANALYSIS; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTOR; SEX RATIO; SEXUAL DEVELOPMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84908295486     PISSN: 00220736     EISSN: 15328430     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2014.08.007     Document Type: Article

References (24)

1. C.M. Tracy, A.E. Epstein, D. Darbar, J.P. Dimarco, S.B. Dunbar, and N.A. Estes III 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 1297 1313
2. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, and J. McMurray 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
3. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators [see comments] N Engl J Med 337 1997 1576 1583
4. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, and D.S. Cannom Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
5. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, and R. Boineau Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
6. C.S. Fox, J.C. Evans, M.G. Larson, W.B. Kannel, and D. Levy Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study Circulation 110 2004 522 527
7. W.B. Kannel, P.W. Wilson, R.B. D'Agostino, and J. Cobb Sudden coronary death in women Am Heart J 136 1998 205 212
8. R. Lampert, C.A. McPherson, J.F. Clancy, T.L. Caulin-Glaser, L.E. Rosenfeld, and W.P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators J Am Coll Cardiol 43 2004 2293 2299
9. J.G. Wigginton, P.E. Pepe, J.P. Bedolla, L.A. DeTamble, and J.M. Atkins Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-based study Crit Care Med 30 2002 S131 S136
10. M.C. Haigney, W. Zareba, J.M. Nasir, S. McNitt, D. McAdams, and P.J. Gentlesk Gender differences and risk of ventricular tachycardia or ventricular fibrillation Heart Rhythm 6 2009 180 186
11. M.D. Drici, T.R. Burklow, V. Haridasse, R.I. Glazer, and R.L. Woosley Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart Circulation 94 1996 1471 1474
12. P.N. Peterson, S.L. Daugherty, Y. Wang, H.J. Vidaillet, P.A. Heidenreich, and J.P. Curtis Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy Circulation 119 2009 1078 1084
13. J.A. Dodson, M.R. Reynolds, H. Bao, S.M. Al-Khatib, E.D. Peterson, and M.S. Kremers Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry) J Am Coll Cardiol 63 2014 788 796
14. D.R. MacFadden, E. Crystal, A.D. Krahn, I. Mangat, J.S. Healey, and P. Dorian Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database Ann Intern Med 156 2012 195 203
15. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, and K.P. Anderson Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
16. W. Zareba, A.J. Moss, W. Jackson Hall, D.J. Wilber, J.N. Ruskin, and S. McNitt Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction J Cardiovasc Electrophysiol 16 2005 1265 1270
17. A.M. Russo, J.E. Poole, D.B. Mark, J. Anderson, A.S. Hellkamp, and K.L. Lee Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial J Cardiovasc Electrophysiol 19 2008 720 724
18. C.M. Albert, R. Quigg, S. Saba, N.A. Estes III, A. Shaechter, and H. Subacius Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy Am Heart J 156 2008 367 372
19. H. Ghanbari, G. Dalloul, R. Hasan, M. Daccarett, S. Saba, and S. David Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials Arch Intern Med 169 2009 1500 1506
20. P. Santangeli, G. Pelargonio, A. Dello Russo, M. Casella, C. Bisceglia, and S. Bartoletti Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis Heart Rhythm 7 2010 876 882
21. S. Zabarovskaja, F. Gadler, F. Braunschweig, M. Casella, C. Bisceglia, and S. Bartoletti Women have better long-term prognosis than men after cardiac resynchronization therapy Europace 14 2012 1148 1155
22. J.J. Goldberger, and A.E. Buxton Personalized medicine vs guideline-based medicine JAMA 309 2013 2559 2560
23. A.C. van der Heijden, J. Thijssen, C.J. Borleffs, J.B. van Rees, U. Höke, and E.T. van der Velde Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients Heart 99 2013 1244 1249
24. S.C. Wijers, B.Y. van der Kolk, A.E. Tuinenburg, P.A. Doevendans, M.A. Vos, and M. Meine Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: which patients do benefit? Neth Heart J 21 2013 274 283